Cocci Bol-O-Tab 1.296 g Bolus is a Health Canada–registered veterinary drug (DIN 00714984) held by Intervet Canada Corp, containing Sulfacetamide Sodium. Health Canada lists its status as Cancelled Post Market (status date 05 Aug 2008). Nexara Health has matched 48 registrations of Sulfacetamide Sodium across 7 other regulated markets.
Health Canada registration
| DIN | 00714984 |
|---|---|
| Brand name | Cocci Bol-O-Tab |
| Active ingredient | Sulfacetamide Sodium |
| Strength | 1.296 g |
| Dosage form | Bolus |
| Route | Oral |
| Company | Intervet Canada Corp |
| Status | Cancelled Post Market — 05 Aug 2008 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Sulfacetamide Sodium registered in other markets
48 registrations of the same molecule in 7 national registries outside Canada (first 27 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Finland | Isopto-Cetamide | Alcon Couvreur N.V. | 150 mg/ml | silmätipat | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Minims Sulphacetamid | Chauvin Pharmaceuticals Limited | 100 mg/ml | silmätipat | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Oftan-Sulfa | Schering Oy | 150 mg/ml | silmätipat | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Poland | Sulfacetamidum Polpharma | Zakłady Farmaceutyczne POLPHARMA S.A. | 100 mg/ml | Krople do oczu | 2025-04-17 | URPL RPL |
| Poland | Sulfacetamidum WZF 10 % HEC | Blau Farma Group Sp. z o.o. - S.K.A. | 100 mg/ml | Krople do oczu | 2024-12-30 | URPL RPL |
| Saudi Arabia | Apisulfa 20% Eye Drops | — | 20 | Inactive | SFDA | |
| Saudi Arabia | Cetamide 10% Opth.oint. | — | 10 | Inactive | SFDA | |
| Saudi Arabia | Colircusi Sulphacetamide 10% | — | 10 | Inactive | SFDA | |
| Saudi Arabia | Colircusi Sulphacetamide 20% | — | 20 | Inactive | SFDA | |
| Saudi Arabia | Isopto Cetamide 10% Eye Drops | — | 10 | Inactive | SFDA | |
| Saudi Arabia | Isoptocetamide 15% Eye Drops | — | 15 | Inactive | SFDA | |
| Saudi Arabia | Riacetamide | — | 10 | Inactive | SFDA | |
| Saudi Arabia | Riacetamide | — | 10 | Inactive | SFDA | |
| South Africa | Lennon Sulphacetamide Eye Ointment | Pharmacare Limited, Woodmead | 350 mg/3.5g | Eyo | S2 | DoH SEP database |
| Taiwan | Sulf-10 | Maurry Biological Co. Inc. | 點眼液劑 | 已註銷 | TFDA | |
| Taiwan | Summer Eye Drops "Sun" | 大陽製藥股份有限公司 | 點眼液劑 | 已註銷 | TFDA | |
| Turkey | Siveklin %10 Losyon (50gr) | Argi̇s İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Aktif | TITCK | ||
| Turkey | Sivex 50 Gr Losyon | Orva İlaç San. Ve Ti̇c. A.ş. | Aktif | TITCK | ||
| Turkey | Sulfafur %10 Krem (30g) | Assos İlaç Ki̇mya Gida Ürünleri̇ Üreti̇m Ve Ti̇c. A.ş. | Aktif | TITCK | ||
| United States | Klaron | Bausch Health US, LLC | Lotion | listed | FDA NDC | |
| United States | Ovace | Mission Pharmacal Company | Liquid | listed | FDA NDC | |
| United States | Ovace Plus | Mission Pharmacal Company | Lotion | listed | FDA NDC | |
| United States | OVACE Plus | Mission Pharmacal Company | Liquid | listed | FDA NDC | |
| United States | OVACE Plus | Mission Pharmacal Company | Shampoo | listed | FDA NDC | |
| United States | OvacePlus Plus | Mission Pharmacal Company | Cream | listed | FDA NDC | |
| United States | Plexion Ns | Eckson Labs, LLC | Shampoo | listed | FDA NDC | |
| United States | Sodium Sulfacetamide, Sulfur | BioComp Pharma, Inc. | Cream | listed | FDA NDC |
See every manufacturer of Sulfacetamide Sodium worldwide →
Regulator price references for Sulfacetamide Sodium
Published list or reimbursement prices for Sulfacetamide Sodium presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Saudi Arabia | Apisulfa 20% Eye Drops | 20pct | 2.45 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Colircusi Sulphacetamide 20% | 20pct | 3.05 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Colircusi Sulphacetamide 10% | 10pct | 4.75 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Riacetamide | 6.85 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Riacetamide -20 | 6.85 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Isoptocetamide 15% Eye Drops | 15pct | 8.40 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Cetamide 10% Opth.oint. | 10pct | 8.45 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Riacetamide | 10.45 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Isopto Cetamide 10% Eye Drops | 10pct | 15.85 SAR | public | SFDA | 2026-09-01 | |
| South Africa | Lennon Sulphacetamide Eye Ointment | 350mg/3500mg | 3.5 | 37.62 ZAR | single exit price | DoH SEP database | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Cocci Bol-O-Tab (DIN 00714984) marketed in Canada?
No. Health Canada lists DIN 00714984 as Cancelled Post Market as of 05 Aug 2008.
Who holds the Canadian licence for this product?
Intervet Canada Corp is the company of record in the Health Canada Drug Product Database.
Is Sulfacetamide Sodium registered outside Canada?
Yes — Nexara Health has matched 48 registrations in 7 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00714984, status date 2008-08-05; national medicine registries: DoH SEP database, FDA NDC, Fimea Perusrekisteri, SFDA, TFDA, TITCK, URPL RPL; price sources: DoH SEP database, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00714984, status date 2008-08-05; national medicine registries: DoH SEP database, FDA NDC, Fimea Perusrekisteri, SFDA, TFDA, TITCK, URPL RPL; price sources: DoH SEP database, SFDA.
Health Canada Drug Product Database (DPD), DIN 00714984, status date 2008-08-05; national medicine registries: DoH SEP database, FDA NDC, Fimea Perusrekisteri, SFDA, TFDA, TITCK, URPL RPL; price sources: DoH SEP database, SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.